Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rozman

Showing results (561-570 of 563) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 563 results.
Bone Marrow Transplantation|September 26, 2001
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantationA Urbano-Ispizua, S Brunet, C Solano, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
Leukemia|August 26, 2014
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impactA C Queirós, N Villamor, G Clot, et al.
Pageof 57

Showing results (561-570 of 563) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 563 results.
Bone Marrow Transplantation|September 26, 2001
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantationA Urbano-Ispizua, S Brunet, C Solano, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
Leukemia|August 26, 2014
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impactA C Queirós, N Villamor, G Clot, et al.
Pageof 57